Literature DB >> 7591842

Expression of laminin subunits in human fetal skeletal muscle.

C A Sewry1, M Chevallay, F M Tomé.   

Abstract

The laminin variant of adult skeletal muscle fibres and Schwann cells is known as merosin, and is composed of M-B1-B2 chains. Blood vessels and immature fibres express the A chain in association with B1 or S, and B2. The importance of merosin has recently been shown by its absence in one form of congenital muscular dystrophy and in the mutant dy/dy mouse, and by its partial deficiency in Fukuyama congenital muscular dystrophy. We have examined the immunocytochemical localization of the M, A, B1 and B2 laminin chains in human fetal muscle from 7 to 40 weeks' gestation to ascertain their developmental expression. The B1 and B2 chains were detected on muscle fibres at 7 weeks, but only traces of the A or M chain were seen. By 21 weeks maximal levels of all four subunits were observed on all fibres. This suggests that the basement membrane is still being assembled until this stage of development. Expression of the A chain on muscle fibres was not reduced until 34 weeks and low levels persisted at birth. The concomitant expression of the M and A chains at early stages may indicate a laminin variant, in addition to merosin, that is highly expressed in fetal muscle. Merosin was seen in intramuscular nerves at 11 weeks. B1 and B2 subunits were detected in blood vessels from 7 weeks' gestation and the A chain from 11 weeks. The capillary network, however, is not fully established in fetal muscle. Merosin is therefore detected early during human fetal muscle development, and this should be taken into account when assessing aborted fetuses at risk for congenital muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591842

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  25 in total

1.  Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.

Authors:  K Ehrig; I Leivo; W S Argraves; E Ruoslahti; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Abnormal localization of laminin subunits in muscular dystrophies.

Authors:  Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

3.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

4.  Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.

Authors:  Y Sunada; S M Bernier; C A Kozak; Y Yamada; K P Campbell
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

5.  Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations.

Authors:  Y Fukuyama; M Osawa; H Suzuki
Journal:  Brain Dev       Date:  1981       Impact factor: 1.961

6.  Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle.

Authors:  A Clerk; G E Morris; V Dubowitz; K E Davies; C A Sewry
Journal:  Histochem J       Date:  1993-08

7.  Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.

Authors:  T Toda; M Segawa; Y Nomura; I Nonaka; K Masuda; T Ishihara; M Sakai; I Tomita; Y Origuchi; M ] Suzuki M [corrected to Sakai
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

8.  Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle.

Authors:  J Philpot; C Sewry; J Pennock; V Dubowitz
Journal:  Neuromuscul Disord       Date:  1995-07       Impact factor: 4.296

9.  Congenital muscular dystrophy with merosin deficiency.

Authors:  F M Tomé; T Evangelista; A Leclerc; Y Sunada; E Manole; B Estournet; A Barois; K P Campbell; M Fardeau
Journal:  C R Acad Sci III       Date:  1994-04

10.  Prenatal diagnosis in congenital muscular dystrophy.

Authors:  F Muntoni; C Sewry; L Wilson; C Angelini; C P Trevisan; B Brambati; V Dubowitz
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

View more
  10 in total

1.  Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle.

Authors:  U M Wewer; L E Thornell; F Loechel; X Zhang; M E Durkin; S Amano; R E Burgeson; E Engvall; R Albrechtsen; I Virtanen
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.

Authors:  P H Vachon; H Xu; L Liu; F Loechel; Y Hayashi; K Arahata; J C Reed; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Skeletal muscle morphology in power-lifters with and without anabolic steroids.

Authors:  Anders Eriksson; Fawzi Kadi; Christer Malm; Lars-Eric Thornell
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

4.  Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry.

Authors:  R Herrmann; V Straub; K Meyer; T Kahn; M Wagner; T Voit
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

5.  Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.

Authors:  Kinga I Gawlik; Madeleine Durbeej
Journal:  Skelet Muscle       Date:  2011-03-01       Impact factor: 4.912

6.  The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.

Authors:  J H Miner; B L Patton; S I Lentz; D J Gilbert; W D Snider; N A Jenkins; N G Copeland; J R Sanes
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

7.  Laminin-induced acetylcholine receptor clustering: an alternative pathway.

Authors:  J E Sugiyama; D J Glass; G D Yancopoulos; Z W Hall
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

8.  Unilateral muscle overuse causes bilateral changes in muscle fiber composition and vascular supply.

Authors:  Yafeng Song; Sture Forsgren; Jing-Xia Liu; Ji-Guo Yu; Per Stål
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

9.  Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival.

Authors:  P H Vachon; F Loechel; H Xu; U M Wewer; E Engvall
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

10.  Congenital muscular dystrophy with inflammation: Diagnostic considerations.

Authors:  Kaumudi Konkay; Meena Angamuthu Kannan; Lokesh Lingappa; Megha S Uppin; Sundaram Challa
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.